artificial intelligence
HIMSS21
Industry leaders discussed the state of healthcare data analytics today at HIMSS21.
Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.
The company says that the chatbot combines AI with the type of healthcare that regards a patient's customs and beliefs.
Through video calls, Opsis Emotion AI’s software will be used by counsellers to help diagnose mental health conditions such as anxiety, stress and depression.
The company claims that the testing solution checks the spectral signature of a virus from a nasal or mouthwash sample to detect COVID-19 within seconds.
Fred IT claims that it is enabling Australia's first use of AI in pharmacy dispensing.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.
The health startup provides telemedicine services for insurance companies, corporations and government entities.
The risk assessment tool can potentially determine if plaque build-up has narrowed a patient's coronary arteries.
The technology can detect 588 common and rare skin conditions in 133 categories.